All resources are organized into categories. Click the arrow to reveal the subcategories within each category. Click any category or subcategory to view all the resources it contains.
Enter words or phrases to search for resources. Note: This searches on the resource titles and descriptions, but does not currently search the content of the resources (e.g., the text in a PDF).
Tick the boxes to search any combination of category, resource format, author, publication date, and whether a resource is peer reviewed or available in French. As you check and uncheck items, the count of matching resources will update. Click the blue “SHOW RESULTS” button to view resources that match the criteria you have selected.
This webinar hosted by the DMPA-SC Access Collaborative Learning and Action Networks (LAN) on July 21, 2021 highlighted important considerations for private pharmacies in data collection and reporting on self-care products such as DMPA-SC self-injection. Presenters shared their experiences and lessons from introducing DMPA-SC self-injection through private delivery channels in their respective countries.
Highlights included:
This virtual discussion encouraged all stakeholders—program implementers, researchers, government officials, health providers, and civil society members—to consider private sector perspectives on data collection and reporting practices, highlighting the importance of good private sector data to inform government policies and strategies for monitoring, regulating health products, and procurement.
Institutional author(s): PATH, JSI, inSupply Health, Pharmaceutical Society of Kenya, Pharmaceutical Society of Zambia
Publication date: July, 2021
This guidance from the World Health Organization (WHO) aims to provide a people-centred, evidence-based normative guideline that will support individuals, communities, and countries with quality health services and self-care interventions, based on PHC strategies, comprehensive essential service packages and people-centredness. The guidance includes a “strong” recommendation for self-administered injectable contraception, stating that this should be made available as an additional approach to deliver injectable contraception for individuals of reproductive age.
Institutional author(s): World Health Organization (WHO)
Publication date: June, 2021
Over the past two years, a number of implementing partners have leveraged the Catalytic Opportunity Fund (COF) to support the scale-up of DMPA-SC in focal countries. The COF is a rapid funding mechanism administered by Clinton Health Access Initiative (CHAI) and managed by the DMPA-SC Operations Group, a group that responds to operational and service delivery issues in DMPA-SC and self-injection introduction and scale-up. The fund aims to support short-term DMPA-SC scale-up activities that unlock or generate additional resources. COF grantees carry out a diverse range of activities with short-term, small grants that make significant contributions to the national introduction and scale-up of DMPA-SC in their countries.
During this DMPA-SC Learning and Action Network (LAN) knowledge-sharing webinar held on May 19, 2021, successful COF grantees representing the Society for Family Health, Pathfinder International, Marie Stopes, and Jhpiego shared about the fund’s impact on their work and key lessons learned. The virtual discussion encouraged all stakeholders—program implementers, researchers, government officials, health providers, and members of civil society—to consider applicable strategies and mechanisms for efficient, sustainable, and scalable product introduction.
For more information, please contact the Access Collaborative LAN at dmpa-sc-lan@path.org or the CHAI COF at COF@clintonhealthaccess.org.
Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), JSI, Society for Family Health, Pathfinder International, MSI Reproductive Choices, Jhpiego
Publication date: May, 2021
The DMPA-SC Access Collaborative hosted this April 21, 2021 webinar highlighting lessons learned to date through four years of data-driven technical assistance and coordination to ensure that women have increased access to self-injection as a contraceptive option, delivered through informed choice programming. The discussion focused on key topics for the introduction and scale-up of self-injection—and self-care interventions more broadly—at the country level including:
This discussion was moderated by Monica Mutesa, Zambia Country Coordinator, DMPA-SC Access Collaborative, PATH. Speakers included:
For more information, please contact FPoptions@path.org.
Institutional author(s): PATH, JSI
Publication date: April, 2021
In this Making Self-Injection Count workshop session, participants were engaged in a lively discussion and interactive collaboration around the important considerations for private sector data collection and reporting on self-care products such as DMPA-SC. This session began with a short presentation to set the stage on the important role of private sector and data within the context of mixed health systems. Participants joined a moderated discussion with three in-country implementers from Nigeria (DKT), Uganda (PSI) and Zambia (JSI) who shared their experiences and lessons from introducing DMPA SC self-injection and other self-care products through private delivery channels. The session concluded with a facilitated, interactive activity to identify and prioritize private sector data needs.
Objectives
By the end of the session, participants were able to:
Key takeaways
Presenters
Institutional author(s): PATH, JSI
Publication date: March, 2021
Participants in this Making Self-Injection Count workshop session learned about interim data sources for self-injection data, including Performance Monitoring for Action (PMA) surveys, demographic and health surveys (DHS) surveys, and low-resource, short-term auxiliary data collection systems. This session also highlighted efforts made to collect and use family planning data in humanitarian settings. Presenters addressed general timelines for data access in different countries and evaluated differences in indicators across data sets.
Objectives
By the end of the session, participants were able to:
Key takeaways
Presenters
Institutional author(s): PATH, JSI
Publication date: March, 2021
This session wrapped up the Making Self-Injection Count workshop and highlighted key takeaways. Participants had an opportunity to reflect on what they learned and the action steps they have identified to move forward with their work.
Key takeaways
The workshop closed with four calls to action:
Presenter
Institutional author(s): PATH, JSI
Publication date: March, 2021
This was a hands-on skill-building session during the Making Self-Injection Count workshop in which participants worked with a sample data set in order to create data visualizations using Microsoft Excel. Two versions of the session were offered—a beginner session for participants with limited experience using Excel and data visualizations, and an advanced session for those with more experience. Participants needed a computer with Excel; the dataset and other materials were provided.
Objectives
By the end of the session, participants were able to:
Key takeaways
Presenters
Institutional author(s): PATH, JSI
Publication date: March, 2021
In this practical, hands-on simulated data use session in the Making Self-Injection Count workshop, participants first learned about experiences running data review meetings in Kenya and Tanzania, highlighting lessons learned and best practices. Then they practiced skills using a mock decision-support tool to solve a common self-injection data challenge.
Objectives
By the end of the session, participants were able to:
Key takeaways
Presenters
Institutional author(s): PATH, JSI
Publication date: March, 2021
This session of the Making Self-Injection Count workshop took an advocacy lens to highlight the importance of self-injection data. Representatives from the Government of Malawi—which has included self-injection in their HMIS since 2019—shared an overview of their self-injection program, highlighting the process for updating their HMIS including success and challenges. They also highlighted how self-injection data has been used at the national and district program levels. Participants had an opportunity to ask questions during the question and answer session.
Objectives
By the end of this session, participants were able to:
Key takeaways
Presenters
Institutional author(s): PATH, JSI, Malawi Ministry of Health, Clinton Health Access Initiative (CHAI)
Publication date: March, 2021